Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trialErnst-Rüdiger Kuse, Oliver A. Cornely, Carlos H. Barrios et al.|The Lancet|2007Cited by 689
Clinical and Economic Outcomes in Critically Ill Patients with Nosocomial Catheter-Related Bloodstream InfectionsStijn Blot, K. Vandewoude, P. Depuydt et al.|Clinical Infectious Diseases|2005Cited by 425
Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapyBarbara Claus, Jan J. De Waele, Eric A. J. Hoste et al.|Journal of Critical Care|2013Cited by 216
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Mieke Carlier, Jan J. De Waele, Sofie Carrette et al.|Critical Care|2013Cited by 212
Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trialJan J. De Waele, Alain Verstraete, Sofie Carrette et al.|Intensive Care Medicine|2013Cited by 190